Reviva Pharmaceuticals Holdings, Inc.
RVPH· OTC
RVPHReviva Pharmaceuticals Holdings, Inc.
Filed Jan 10, 2020 · 10-Q · 41 days after period end · 0001104659-20-003044
| Metric | Q3 2019 | Q3 2018 |
|---|---|---|
| Net Income | $136.81K | $263.22K |
| EPS Diluted | -$0.05 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Reviva Pharmaceuticals Holdings, Inc. · CIK 1742927 · Engraved from SEC EDGAR
ended Nov 30, 2019 · filed Jan 10, 2020 · 41 d after period end
